Today's Daily Dose brings you news about the Fast Track Designation granted for Anavex Life Sciences' lead asset ANAVEX2-73; Insmed's phase II WILLOW study; Rockwell Medical's public offering of common stock and disappointing results from United Therapeutics' DISTINCT study.
from RTT - Biotech https://ift.tt/3bbJN4v
via IFTTT
No comments:
Post a Comment